Fig. 2: HECT E3 ubiquitin ligase gene expression level in SARS-CoV-2 positive and negative groups of subjects. | Cell Death & Disease

Fig. 2: HECT E3 ubiquitin ligase gene expression level in SARS-CoV-2 positive and negative groups of subjects.

From: Inhibition of HECT E3 ligases as potential therapy for COVID-19

Fig. 2

A NEDD4 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, exact p value p = 0.0016, **; B WWP1 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, exact p value p = 0.0005, ***; C WWP2 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, exact p value p = 0.0038, **; D SMURF1 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, exact p value p = 0.044, *; E SMURF2 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, non-significant p value; F NEDD4L expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, non-significant p value; G ITCH expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, non-significant p value; H HECW1 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, non-significant p value; I HECW2 expression level in SARS-CoV-2 positive and negative groups of subjects, Mann–Whitney test, non-significant p value.

Back to article page